Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BAKER S. P. Heparin-activated clearing factor; standardized test, agewise application, and clinical observations. Circulation. 1957 Jun;15(6):889–896. doi: 10.1161/01.cir.15.6.889. [DOI] [PubMed] [Google Scholar]
- BAKER S. P., LEVINE H., TURNER L., DUBIN A. Lipoprotein lipase response in Laennec's cirrhosis. Proc Soc Exp Biol Med. 1958 Dec;99(3):670–672. doi: 10.3181/00379727-99-24458. [DOI] [PubMed] [Google Scholar]
- BLOCK W. J., BARKER N. W., MANN F. D. Effect of small doses of heparin in increasing the translucence of plasma during alimentary lipemia; studies in normal persons and patients having arteriosclerosis. Circulation. 1951 Nov;4(5):674–678. doi: 10.1161/01.cir.4.5.674. [DOI] [PubMed] [Google Scholar]
- CISWICKA M., MICHAJLIK A., SZNAJDERMAN M. Studies on the lipolytic activity of blood serum in atherosclerosis. Acta Med Scand. 1958 Jul 7;161(5):391–395. doi: 10.1111/j.0954-6820.1958.tb15554.x. [DOI] [PubMed] [Google Scholar]
- CONNOR W. E., ECKSTEIN J. W. The removal of lipoprotein lipase from the blood by the normal and diseased liver. J Clin Invest. 1959 Oct;38:1746–1755. doi: 10.1172/JCI103953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CONSTANTINIDES P., SO Y., JOHNSTONE F. R. Role of liver and kidney in development of heparin-induced lipemia clearing activity. Proc Soc Exp Biol Med. 1959 Feb;100(2):262–264. doi: 10.3181/00379727-100-24593. [DOI] [PubMed] [Google Scholar]
- DAY A. J., WILKINSON G. N. Clearing factor inhibitor in human atherosclerosis. Circulation. 1958 Jul;18(1):76–81. doi: 10.1161/01.cir.18.1.76. [DOI] [PubMed] [Google Scholar]
- DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HERZSTEIN J., WANG C. I., ALDERSBERG D. Effect of heparin on plasma lipid partition in man: studies in normal persons and in patients with coronary atherosclerosis, nephrosis and primary hyperlipemia. Ann Intern Med. 1954 Feb;40(2):290–305. doi: 10.7326/0003-4819-40-2-290. [DOI] [PubMed] [Google Scholar]
- HOOD B., ANGERWALL G., ISAKSSON B., WELIN G. Studies on heparin and the lipemia clearing factor. I. Scand J Clin Lab Invest. 1954;6(1):1–7. [PubMed] [Google Scholar]
- JEFFRIES G. H. The sites at which plasma clearing activity is produced and destroyed in the rat. Q J Exp Physiol Cogn Med Sci. 1954;39(4):261–270. doi: 10.1113/expphysiol.1954.sp001080. [DOI] [PubMed] [Google Scholar]
- OLIVER M. F., BOYD G. S. The clearing by heparin of alimentary lipaemia in coronary artery disease. Clin Sci. 1953;12(3):293–298. [PubMed] [Google Scholar]
- SANDHOFER F., SAILER S., BRAUNSTEINER H. [Research on lipoprotein lipase. III. Post-heparin lipoprotein lipase in man under normal and pathological conditions]. Klin Wochenschr. 1961 Sep 15;39:968–971. doi: 10.1007/BF01482657. [DOI] [PubMed] [Google Scholar]
- SPITZER J. A., SPITZER J. J. Effect of liver on lipolysis by normal and post-heparin sera in the rat. Am J Physiol. 1956 Apr;185(1):18–22. doi: 10.1152/ajplegacy.1956.185.1.18. [DOI] [PubMed] [Google Scholar]
- STEIN Y., TIETZ A., SHAPIRO B. Glyceride synthesis by rat liver mitochrondria. Biochim Biophys Acta. 1957 Nov;26(2):286–293. doi: 10.1016/0006-3002(57)90007-0. [DOI] [PubMed] [Google Scholar]
- STORK A., KUCEROVA L. Die Klärungsfähigkeit des Blutplasmas und Veränderungen des Plasmacholesterinspiegels nach intravenöser Heparininjektion bei Diabetikern und Atherosklerotikern. Dtsch Med Wochenschr. 1957 Aug 30;82(35/I):1410–1413. [PubMed] [Google Scholar]
